OOIR: Observatory of International Research

Papers

(The TQCC of Clinics in Laboratory Medicine is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Strategic Leadership in Laboratory Medicine: Navigating Belonging, Resilience, and Organizational Culture	21
Forthcoming Issues	18
Promoting Health Equity Through Effective Laboratory Stewardship Strategies	15
Digital Imaging and AI Pre-classification in Hematology	15
Current Topics in Molecular Diagnostics and Precision Medicine	14
Molecular Detection of Oncogenic Gene Rearrangements	13
Treatment Considerations of Myelodysplastic Syndromes/Neoplasms for Pathologists	11
Point-of-Care Drug Testing	11
Contributors	11
Molecular Pathology of Ovarian Epithelial Neoplasms	11
Copy Number Analysis in Cancer Diagnostic Testing	10
Is It Possible to Test for Viral Infectiousness?	10
Leadership's Role in Paving the Path to Diversity, Equity, and Inclusion in Laboratory Medicine	10
Automated Quality Assurance Rules for Liquid Chromatography–Mass Spectrometry Testing in a Clinical Laboratory	10
Molecular Oncology Diagnostics	10
Inclusive Laboratory Reference Intervals and Clinical Studies to Reduce Health Disparities	9
Flow Cytometry-based Immune Phenotyping of T and B Lymphocytes in the Evaluation of Immunodeficiency and Immune Dysregulation	9
Nothing Basic About It: Guiding the Judicious Use of Diagnostic Tests	8
Flow Cytometry and Platelets	8
Contributors	8
Perspectives on Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 and Its Implications for Diagnostics, Biology, and Clinical Management	8
Flow Cytometry in Diagnosis, Prognostication, and Monitoring of Multiple Myeloma and Related Disorders	8
Contributors	8
Cell-free Nucleic Acids in Cancer	8
Opportunities and Challenges with Artificial Intelligence in Genomics	8

Diagnosis and Classification of Myelodysplastic Syndromes with Mutated TP53	7
Artificial Intelligence for Clinical Flow Cytometry	7
Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing	7
Contextualizing Race and Ethnicity in the Practice of Laboratory Medicine	7
Leadership Approaches for Work-Life Balance, Well-Being, and Diversity, Equity, and Inclusion Support in the Laboratory	7
Contents	7
Diagnostic Stewardship for Next-Generation Sequencing Assays in Clinical Microbiology	7
Contents	6
Expanding the Blood Donor Pool	5
The Evolving Role of Molecular Diagnostics in Pathology	5
Copyright	5
Molecular Alterations in Pediatric Solid Tumors	5
Copyright	5
An Overview of SARS-CoV-2 Molecular Diagnostics in Europe	5
The Impact of Inclusive Excellence Initiatives on Laboratory Wellness	5
Electronic Health Record Optimization for Artificial Intelligence	5
Detection of SARS-CoV-2 Antibodies in Diagnosis and Treatment of COVID-19	5
Morphologic Characteristics of Myelodysplastic Syndromes	5
Steps Forward to a Fair and Inclusive Blood Supply	5
Implementation of Viscoelastic Testing at the Point of Care	5
Hemostatic Disorders Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection, COVID-19 Vaccination, and Long-COVID Syndrome	4
Artificial Intelligence in the Clinical Laboratory	4
Review of Established and Emerging Infectious Diseases in Transfusion Medicine	4
The Role of Artificial Intelligence in Transfusion Medicine	4
Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance)	4
Utility of Single-Gene Testing in Cancer Specimens	4
von Willebrand Disease and von Willebrand Factor	4
Transfusion Medicine: Renovation, Innovation, and Evolution	4
Molecular Biomarkers of Response to Cancer Immunotherapy	4
Taking Center Stage	4
Rapid Antigen Assays for SARS-CoV-2	4
Copyright	4
Molecular Diagnostics for Invasive Molds: From Lab to Bedside	4
The Mass Spectrometry Revolution in Clinical Microbiology Part 2	4
Point of Care Molecular Testing	4
Contents	3
Suboptimal Humoral Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Viral Variant Generation	3
Performance Evaluation of Lateral Flow Assays for Coronavirus Disease-19 Serology	3
Flow Cytometric Assessment of Myelodysplastic Syndromes/Neoplasms	3
An Overview of Common Donor and Therapeutic Apheresis Procedures	3
Contributors	3
Diagnostic Stewardship for Multiplex Respiratory Testing	3
Copyright	3
Update on Ovarian Sex Cord–Stromal Tumors	3
Bacterial Risk Mitigation Strategies for Platelets	3
Value of Improving Result Interpretation in Direct-to-Definitive Urine Drug Panels	3
A Meta-analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Anti-spike Immunoglobulin G Antibody Durability up to 9 Months After Full Vaccination in Adults	3
Performance of Non-nasopharyngeal Sample Types for Molecular Detection of SARS-CoV-2	3
Contents	3
Molecular Methods	3

Copyright	3
Influence of Race Modifiers in Estimated Glomerular Filtration Rate Calculations on Medication Dosing, Access, and Transplant Eligibility	3